The fear of the unknown at the beginning of the COVID pandemic drove Pfizer to find solutions to the health crisis being seen right across the world.
“We took everything that we’ve learnt before and designed a clinical trial program that could move as efficiently as possible, as rapidly as possible whilst of course making sure that the vaccine was safe,” Stephen Lockhart, Vice President, Head of Europe and Asia-Pacific, Vaccine Clinical Research and Development, Pfizer told Sky News.
“And putting that all together, we’ve worked collaboratively with a huge number of people.”
The Alliance is presented by Pfizer.
Read the full article here
